Africa Corporate Wellness Market, by End User, 2018-2027
Global Irritable Bowel Syndrome Treatment market [2015-2023] Middle East and Africa by Drug Type
By Drug Type, the market is segmented into Lubiprostone, Linaclotide, Eluxadoline, Rifaximin, Alosetron, and Others (2015-2023)
| Label | Lubiprostone | Linaclotide | Eluxadoline | Rifaximin | Alosetron | Others |
|---|---|---|---|---|---|---|
| 2015 | 30 USD Mn | 38 USD Mn | 28.8 USD Mn | 8.6 USD Mn | 4.7 USD Mn | 8.9 USD Mn |
| 2016 | 33.7 USD Mn | 42.4 USD Mn | 32.3 USD Mn | 9.7 USD Mn | 5.2 USD Mn | 10 USD Mn |
| 2017 | 37.4 USD Mn | 46.6 USD Mn | 35.8 USD Mn | 10.7 USD Mn | 5.8 USD Mn | 11.1 USD Mn |
| 2018 | 40.7 USD Mn | 50.5 USD Mn | 39 USD Mn | 11.7 USD Mn | 6.3 USD Mn | 12 USD Mn |
| 2019 | 43.7 USD Mn | 54.2 USD Mn | 41.9 USD Mn | 12.5 USD Mn | 6.8 USD Mn | 12.9 USD Mn |
| 2020 | 46.4 USD Mn | 58 USD Mn | 44.4 USD Mn | 13.3 USD Mn | 7.2 USD Mn | 13.6 USD Mn |
| 2021 | 48.6 USD Mn | 61.3 USD Mn | 46.4 USD Mn | 13.9 USD Mn | 7.5 USD Mn | 14.1 USD Mn |
| 2022 | 50.5 USD Mn | 63.9 USD Mn | 48.2 USD Mn | 14.4 USD Mn | 7.7 USD Mn | 14.5 USD Mn |
| 2023 | 52.3 USD Mn | 66 USD Mn | 49.9 USD Mn | 14.9 USD Mn | 7.9 USD Mn | 14.8 USD Mn |
Data Source: Wantstats Repository
Market Dynamics
linaclotide segment accounted for the largest market share in 2017, this market is expected to reach USD 66.00 Million in 2023 from USD 46.60 Million in 2017. This market is projected to grow at a CAGR of 5.50% during the forecast period from 2018 - 2023.
Research Methodology
Figures reflect Wantstats’ original market research and forecasting models, compiled as part of the Wantstats research archive and published in 2023.
Unlock the Full Data
Get This Chart
Access the complete chart and underlying data to support your research, analysis, and business decisions.
Powering the world's best teams.
From next-gen startups to established enterprises.
Get in Touch
Let's work together
support@wantstats.comSee our work in action
Start your data driven journey with us!
What our clients say
Trusted by forward-thinking businesses
for data-driven intelligence



